Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Semaglutide in Overweight and Obese Patients Undergoing IVF
NCT07242534Phase 4Recruiting
- Sponsor
- Fundación Dexeus Mujer
- Start
- Jan 2026
- Primary completion
- Feb 2027
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of semaglutide in infertility, obesity, sponsored by Fundación Dexeus Mujer. Started Jan 2026; status: recruiting.
02
Drugs
03
Conditions
infertilityobesity
Beyond the preview
Go deeper on NCT07242534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07242534.